News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Cesar Perez: During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents for Head and Neck Cancer
Photo from Cesar Perez/LinkedIn
May 16, 2024, 14:31

Cesar Perez: During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents for Head and Neck Cancer

Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and Research Institute, shared on LinkedIn:

“Drug Development for patients with Head and Neck Cancer has lagged behind over the last decade.

However, a new era is approaching.

During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents in development for the disease, which will bring hope for a population in so much need for new options.

‘Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy’.”

Source: Cesar Perez/LinkedIn

ASCO ASCO 2024 ASCO 2024 Educational Session ASCO Annual Meeting cancer Cesar Perez Florida Cancer Specialists and Research Institute Head and Neck Cancer head and neck squamous cell carcinoma Lake Nona DDU OncoDaily Oncology PD-L1 immunotherapy
Special Coverage
Opinion
Apr 19, 2025, 01:47
Essential Medicines for Children with Cancer: From Access to Action – A Powerful OncoDaily Virtual Forum
Opinion
Apr 19, 2025, 01:45
Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book
Blog
Apr 19, 2025, 01:45
Shray Saheba: I had the exciting opportunity to present my research at the National Research Conference hosted by Brown University
Blog
Apr 19, 2025, 01:42
Highlights from Brown University's Inaugural National Undergraduate Research Conference
Blog
Apr 19, 2025, 01:22
National Cancer Control Plans ensures better prevention, early diagnosis and treatment for all - UICC
Blog
Apr 19, 2025, 01:19
Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide
Science
Apr 19, 2025, 01:13
Filipe Nadir Caparica Santos: The potential of internationally trained physicians
Blog
Apr 19, 2025, 01:05
Join ESTRO 2025 for a series of debate sessions on radiation oncology
Blog
Apr 19, 2025, 01:00
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival
Blog
Apr 19, 2025, 00:20
Heba ElNokoudy: Comprehensive patient counseling significantly reduces adverse drug events
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC